Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer
Authors
Keywords
Gastric cancer, GSI, 5-FU, Combination therapy
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume 32, Issue 6, Pages 593-603
Publisher
Springer Nature
Online
2015-07-01
DOI
10.1007/s10585-015-9730-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Galectin-3 Activates PPARγ and Supports White Adipose Tissue Formation and High-Fat Diet-Induced Obesity
- (2015) Jung-Hwan Baek et al. ENDOCRINOLOGY
- Glucose Deprivation Triggers Protein Kinase C-dependent β-Catenin Proteasomal Degradation
- (2015) Seung-Won Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer
- (2015) Yunhee Cho et al. Oncotarget
- Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy
- (2015) Hyun-Woo Lee et al. BMB Reports
- Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer
- (2015) Seok-Jun Kim et al. Oncotarget
- Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer
- (2015) Seok-Jun Kim et al. Oncotarget
- Ablation of galectin-3 induces p27KIP1-dependent premature senescence without oncogenic stress
- (2014) S-J Kim et al. CELL DEATH AND DIFFERENTIATION
- STAT3 silencing enhances the efficacy of the HSV.tk suicide gene in gastrointestinal cancer therapy
- (2012) Ye-Hyeon Ahn et al. CLINICAL & EXPERIMENTAL METASTASIS
- Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression
- (2012) Yuan-Guo Wang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- S-1 for the treatment of gastrointestinal cancer
- (2012) Taroh Satoh et al. EXPERT OPINION ON PHARMACOTHERAPY
- Current status of targeted therapies in advanced gastric cancer
- (2012) Ferdinando De Vita et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Acceleration of Gastric Tumorigenesis Through MKRN1-Mediated Posttranslational Regulation of p14ARF
- (2012) Aram Ko et al. JNCI-Journal of the National Cancer Institute
- The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia
- (2011) Teresa Palomero et al. CELL CYCLE
- Development of microRNA-145 for therapeutic application in breast cancer
- (2011) Seok-Jun Kim et al. JOURNAL OF CONTROLLED RELEASE
- A SIRT1-LSD1 Corepressor Complex Regulates Notch Target Gene Expression and Development
- (2011) Peter Mulligan et al. MOLECULAR CELL
- CD44, a therapeutic target for metastasising tumours
- (2010) Véronique Orian-Rousseau EUROPEAN JOURNAL OF CANCER
- LRP-1 Promotes Cancer Cell Invasion by Supporting ERK and Inhibiting JNK Signaling Pathways
- (2010) Benoit Langlois et al. PLoS One
- The Activated Notch1 Signal Pathway Is Associated with Gastric Cancer Progression through Cyclooxygenase-2
- (2009) T.-S. Yeh et al. CANCER RESEARCH
- Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents
- (2009) Teak-Chin Cheong et al. CANCER SCIENCE
- Oncogenic NOTCH1 Control of MYC and PI3K: Challenges and Opportunities for Anti-NOTCH1 Therapy in T-Cell Acute Lymphoblastic Leukemias and Lymphomas
- (2008) T. Palomero et al. CLINICAL CANCER RESEARCH
- Notch signaling regulates the FOXP3 promoter through RBP-J- and Hes1-dependent mechanisms
- (2008) Hai-Feng Ou-Yang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Notch signaling mediates hypoxia-induced tumor cell migration and invasion
- (2008) C. Sahlgren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started